Fulton Bank N.A. Sells 495 Shares of Colgate-Palmolive (NYSE:CL)

Fulton Bank N.A. decreased its position in shares of Colgate-Palmolive (NYSE:CL – Get Rating) by 8.8% in the 4th quarter, according to its most recent 13F filing with the SEC. The firm owned 5,112 shares of the company’s stock after selling 495 shares during the quarter. Fulton Bank N.A.’s holdings in Colgate-Palmolive were worth $403,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently made changes to their positions in the company. Vanguard Group Inc. boosted its stake in Colgate-Palmolive by 1.1% in the 3rd quarter. Vanguard Group Inc. now owns 78,638,269 shares of the company’s stock worth $5,524,338,000 after purchasing an additional 882,517 shares during the period. Third Point LLC boosted its stake in Colgate-Palmolive by 481.9% in the 3rd quarter. Third Point LLC now owns 11,550,000 shares of the company’s stock worth $811,388,000 after purchasing an additional 9,565,000 shares during the period. Northern Trust Corp boosted its stake in Colgate-Palmolive by 0.5% in the 1st quarter. Northern Trust Corp now owns 10,470,409 shares of the company’s stock worth $793,971,000 after purchasing an additional 50,040 shares during the period. Legal & General Group Plc boosted its stake in Colgate-Palmolive by 4.1% in the 2nd quarter. Legal & General Group Plc now owns 7,709,706 shares of the company’s stock worth $617,858,000 after purchasing an additional 301,219 shares during the period. Finally, Renaissance Technologies LLC boosted its stake in Colgate-Palmolive by 151.6% in the 1st quarter. Renaissance Technologies LLC now owns 5,688,786 shares of the company’s stock worth $431,381,000 after purchasing an additional 3,427,400 shares during the period. Institutional investors own 77.63% of the company’s stock.

Colgate-Palmolive Price Performance

Shares of Colgate-Palmolive stock opened at $72.20 on Friday. The company has a debt-to-equity ratio of 10.84, a current ratio of 1.28 and a quick ratio of 0.76. The business’s 50 day simple moving average is $74.18 and its two-hundred day simple moving average is $75.04. The stock has a market capitalization of $59.95 billion, a P/E ratio of 33.90, a price-to-earnings-growth ratio of 3.79 and a beta of 0.48. Colgate-Palmolive has a one year low of $67.84 and a one year high of $83.81.

Colgate-Palmolive (NYSE:CL – Get Rating) last announced its quarterly earnings results on Friday, January 27th. The company reported $0.77 EPS for the quarter, hitting analysts’ consensus estimates of $0.77. The business had revenue of $4.63 billion for the quarter, compared to analysts’ expectations of $4.58 billion. Colgate-Palmolive had a return on equity of 317.08% and a net margin of 9.93%. The business’s quarterly revenue was up 5.1% on a year-over-year basis. During the same period in the previous year, the firm earned $0.79 EPS. Analysts forecast that Colgate-Palmolive will post 3.1 EPS for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Monday, May 15th. Shareholders of record on Friday, April 21st will be paid a $0.48 dividend. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.47. This represents a $1.92 dividend on an annualized basis and a yield of 2.66%. The ex-dividend date of this dividend is Thursday, April 20th. Colgate-Palmolive’s payout ratio is 88.26%.

Analyst Ratings Changes

Several analysts have weighed in on CL shares. Citigroup started coverage on Colgate-Palmolive in a report on Thursday, February 16th. They issued a “buy” rating and a $84.00 price target on the stock. Barclays lowered their price target on Colgate-Palmolive from $80.00 to $77.00 and set an “equal weight” rating on the stock in a report on Tuesday, January 31st. Wells Fargo & Company lowered their price target on Colgate-Palmolive from $80.00 to $76.00 and set an “equal weight” rating on the stock in a report on Monday, January 30th. Morgan Stanley raised Colgate-Palmolive from an “equal weight” rating to an “overweight” rating and set a $82.00 price target on the stock in a report on Monday, January 30th. Finally, Deutsche Bank Aktiengesellschaft lowered their price target on Colgate-Palmolive from $87.00 to $84.00 in a report on Monday, January 30th. Six research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and an average price target of $82.09.

Colgate-Palmolive Company Profile

(Get Rating)

Colgate-Palmolive Co is engaged in the manufacturing and distribution of consumer products. It operates through the Oral, Personal and Home Care, and Pet Nutrition segments. The Oral, Personal and Home Care segment represents North America, Latin America, Europe, Asia Pacific, and Africa or Eurasia, all of which sell to a variety of retail and wholesale customers and distributors.